| Myelodysplastic Syndrome/Acute Myeloid Leukemia studied in …STUDIED_INderived10 of 24show all (up to 200) |
|---|
| → studied in | NCT06484062Phase 1 · recruiting Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839771Phase 3 · active not recruiting A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy · condition mapped ALIAS · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530034Phase 1 · active not recruiting Hu8F4 in Treating Patients With Advanced Hematologic Malignancies · condition mapped ALIAS · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816319Phase 1 · active not recruiting TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01522976Phase 2 · active not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719348Phase 1/Phase 2 · not yet recruiting A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357182Phase 1 · recruiting Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02220985Phase 2 · completed Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD · condition mapped ALIAS · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06372717Phase 1 · recruiting A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS · condition mapped CURATED_BROADER · 24 trials mapped (15 active) | — | — | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |